scholarly article | Q13442814 |
P2093 | author name string | Fu Y | |
Sharp BM | |||
Matta SG | |||
James TJ | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | norepinephrine | Q186242 |
P304 | page(s) | 1188-1196 | |
P577 | publication date | 1998-03-01 | |
P1433 | published in | Journal of Pharmacology and Experimental Therapeutics | Q1500272 |
P1476 | title | Nicotine-induced norepinephrine release in the rat amygdala and hippocampus is mediated through brainstem nicotinic cholinergic receptors | |
P478 | volume | 284 |
Q41012076 | Bupropion and nicotine enhance responding for nondrug reinforcers via dissociable pharmacological mechanisms in rats. |
Q51980372 | C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency. |
Q36052826 | Catecholamine outflow from mouse and rat brain slice preparations evoked by nicotinic acetylcholine receptor activation and electrical field stimulation |
Q36403437 | Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation |
Q35734746 | Diversity and distribution of nicotinic acetylcholine receptors in the locus ceruleus neurons. |
Q36570047 | Frontoparietal attentional network activation differs between smokers and nonsmokers during affective cognition. |
Q36560437 | Guidelines on nicotine dose selection for in vivo research. |
Q45998382 | Involvement of alpha1-adrenoceptors in conditioned place preference supported by nicotine in rats. |
Q44348416 | Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice |
Q46364764 | Medication-related pharmacological manipulations of nicotine self-administration in the rat maintained on fixed- and progressive-ratio schedules of reinforcement |
Q44977746 | Modulation of nicotine-induced attentional enhancement in rats by adrenoceptor antagonists. |
Q35802079 | Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states |
Q36137598 | Neuronal nicotinic acetylcholine receptors: neuroplastic changes underlying alcohol and nicotine addictions |
Q34616154 | Neuronal systems underlying behaviors related to nicotine addiction: neural circuits and molecular genetics. |
Q37059455 | Nicotine and nicotinic system in hypoglutamatergic models of schizophrenia |
Q73419638 | Nicotine enhances the biosynthesis and secretion of transthyretin from the choroid plexus in rats: implications for beta-amyloid formation |
Q30372354 | Nicotine modulation of fear memories and anxiety: Implications for learning and anxiety disorders. |
Q34459004 | Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization |
Q37097156 | Nicotinic receptor-evoked hippocampal norepinephrine release is highly sensitive to inhibition by isoflurane |
Q34661063 | Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction |
Q46896371 | Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice |
Q35222799 | The neuropeptide galanin and variants in the GalR1 gene are associated with nicotine dependence |
Q41869437 | The novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB), inhibits nicotine-evoked [(3)H]norepinephrine overflow from rat hippocampal slices |
Q40197322 | Tobacco smoking and the ADRA2A C-1291G polymorphism |
Q42176718 | α7 nicotinic ACh receptor-deficient mice exhibit sustained attention impairments that are reversed by β2 nicotinic ACh receptor activation |
Search more.